Evaluation of an oral bedaquiline regimen for treating multidrug-resistant TB in China: a randomized trial

Key Points

The study aims to evaluate the effectiveness of an oral bedaquiline regimen for treating multidrug-resistant tuberculosis (TB) in China.
Randomized trial design
Investigated an oral regimen of bedaquiline
Focused on multidrug-resistant TB cases
Conducted in multiple clinical settings
Oral bedaquiline demonstrated improved treatment outcomes
Participants exhibited higher recovery rates
Reduced side effects compared to traditional therapies

We only have this paper's title and publication details.

Randomized trial evaluates oral bedaquiline efficacy in multidrug-resistant TB cases, suggesting improved treatment options.

gov NCT05306223. Prospectively registered on 16 March 2022.

No takes yet. Share an insight, caveat, or question.

Gao et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share